Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Chicago, IL
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Gurnee, IL
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Wichita, KA
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
South Dartmouth, MA
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Investigational Site 432
mi
from
South Dartmouth, MA
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Brooklyn Center, MN
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Kansas City, MO
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Lincoln, NE
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Las Vegas, NV
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Edison, NJ
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Edison, NJ
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Endwell, NY
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Burlington, NC
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, NC
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Winston-Salem, NC
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Yukon, OK
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Yukon, OK
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Bensalem, PA
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bensalem, PA
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Mount Pleasant, SC
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Worth, TX
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
New Braunfels, TX
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
West Jordan, UT
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Wauwatosa, WI
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Good Intentions Study
The Impact of Multiple Behavior Change on the Effectiveness of Implementation Intentions to Promote Fitness Center Visitation
Status: Enrolling
Updated:  12/31/1969
mi
from
Grand Forks, ND
Good Intentions Study
The Impact of Multiple Behavior Change on the Effectiveness of Implementation Intentions to Promote Fitness Center Visitation
Status: Enrolling
Updated: 12/31/1969
USDA Grand Forks Human Nutrition Research Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
The Effects of Chia on Overweight/Obese Women
Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Pomona, CA
The Effects of Chia on Overweight/Obese Women
Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
Status: Enrolling
Updated: 12/31/1969
California State Polytechnic University, Pomona
mi
from
Pomona, CA
Click here to add this to my saved trials
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated:  12/31/1969
mi
from
Jackson, MS
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated: 12/31/1969
Central Mississippi Medical Center Comprehensive Weight Management Program
mi
from
Jackson, MS
Click here to add this to my saved trials
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated:  12/31/1969
mi
from
Oxford, MS
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated: 12/31/1969
Oxford Bariatric
mi
from
Oxford, MS
Click here to add this to my saved trials
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated:  12/31/1969
mi
from
Oxford, MS
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated: 12/31/1969
Oxford Surgical & Bariatric Clinic,LLC.
mi
from
Oxford, MS
Click here to add this to my saved trials
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated:  12/31/1969
mi
from
Pascagoula, MS
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Assessment of Outcomes Following Bariatric Surgery for Mississippi State Employees
Status: Enrolling
Updated: 12/31/1969
South Mississippi Surgical Weight Loss Center
mi
from
Pascagoula, MS
Click here to add this to my saved trials
Evaluation of Safety and Health Involvement For Truck Drivers
Social Support During a Randomized Trial of a Trucker Weight Loss Intervention
Status: Enrolling
Updated:  12/31/1969
mi
from
Portland, OR
Evaluation of Safety and Health Involvement For Truck Drivers
Social Support During a Randomized Trial of a Trucker Weight Loss Intervention
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Dietary Approaches for Cardiometabolic Health
Dietary Approaches for Improving Cardiometabolic Health
Status: Enrolling
Updated:  12/31/1969
mi
from
Irvine, CA
Dietary Approaches for Cardiometabolic Health
Dietary Approaches for Improving Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Institute for Clinical and Translational Science
mi
from
Irvine, CA
Click here to add this to my saved trials
Alternate Day Fasting Combined With a High Protein Background Diet
Alternate Day Fasting Combined With a High Protein Background Diet for Weight Loss and Weight Maintenance in Adults With Obesity
Status: Enrolling
Updated:  12/31/1969
mi
from
Chicago, IL
Alternate Day Fasting Combined With a High Protein Background Diet
Alternate Day Fasting Combined With a High Protein Background Diet for Weight Loss and Weight Maintenance in Adults With Obesity
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
A 64-week Pilot Trial to Evaluate the Effects of a Novel Nutraceutical on Weight Loss and Weight Loss Maintenance in Obese Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Gig Harbor, WA
Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
A 64-week Pilot Trial to Evaluate the Effects of a Novel Nutraceutical on Weight Loss and Weight Loss Maintenance in Obese Subjects
Status: Enrolling
Updated: 12/31/1969
Functional Medicine Research Center
mi
from
Gig Harbor, WA
Click here to add this to my saved trials
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures
Status: Enrolling
Updated:  12/31/1969
mi
from
Bristol, CT
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures
Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures
Status: Enrolling
Updated: 12/31/1969
Bristol Hospital
mi
from
Bristol, CT
Click here to add this to my saved trials
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese
Deaf Weight Wise 2.0: Clinical Trial of a Healthy Lifestyle Intervention With Deaf Adults Ages 21 to 70
Status: Enrolling
Updated:  12/31/1969
mi
from
Rochester, NY
Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese
Deaf Weight Wise 2.0: Clinical Trial of a Healthy Lifestyle Intervention With Deaf Adults Ages 21 to 70
Status: Enrolling
Updated: 12/31/1969
University of Rochester; National Center for Deaf Health Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes
Status: Enrolling
Updated: 12/31/1969
Comprehensive Weight Control Center
mi
from
New York, NY
Click here to add this to my saved trials
Multi-site Trial Using SMS to Improve Infant Weight
Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities
Status: Enrolling
Updated:  12/31/1969
mi
from
Honolulu, HI
Multi-site Trial Using SMS to Improve Infant Weight
Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities
Status: Enrolling
Updated: 12/31/1969
University of Hawaii at Manoa
mi
from
Honolulu, HI
Click here to add this to my saved trials
Multi-site Trial Using SMS to Improve Infant Weight
Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities
Status: Enrolling
Updated:  12/31/1969
mi
from
San Juan,
Multi-site Trial Using SMS to Improve Infant Weight
Multi-site Trial Using Short Mobile Messages (SMS) to Improve Infant Weight in Low-income Minorities
Status: Enrolling
Updated: 12/31/1969
University of Puerto Rico, Medical Sciences Campus (UPR-MSC)
mi
from
San Juan,
Click here to add this to my saved trials
Feeding Young Children Study: Bottle Weaning Intervention
Feeding Young Children Study (FYCS)- a Randomized Control Trial of a Bottle Weaning Intervention Aimed at Reducing the Risk of Overweight in Low Income Multi-ethnic Toddlers.
Status: Enrolling
Updated:  12/31/1969
mi
from
Bronx, NY
Feeding Young Children Study: Bottle Weaning Intervention
Feeding Young Children Study (FYCS)- a Randomized Control Trial of a Bottle Weaning Intervention Aimed at Reducing the Risk of Overweight in Low Income Multi-ethnic Toddlers.
Status: Enrolling
Updated: 12/31/1969
Westchester Square WIC
mi
from
Bronx, NY
Click here to add this to my saved trials
A Community-based Study to Target Childhood Obesity
A Culturally-tailored Narrative Intervention to Target Disparities in Obesity
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
A Community-based Study to Target Childhood Obesity
A Culturally-tailored Narrative Intervention to Target Disparities in Obesity
Status: Enrolling
Updated: 12/31/1969
Boston University School of Pblic Health
mi
from
Boston, MA
Click here to add this to my saved trials
Levofloxacin Pharmacokinetics (PK) in the Severely Obese
Levofloxacin Pharmacokinetics in the Severely Obese
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
Levofloxacin Pharmacokinetics (PK) in the Severely Obese
Levofloxacin Pharmacokinetics in the Severely Obese
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
PASOS: Improving the Health of Immigrant Workers
Translating Obesity and Diabetes Prevention Into the Worksite for Immigrant Populations
Status: Enrolling
Updated:  12/31/1969
mi
from
Oxnard, CA
PASOS: Improving the Health of Immigrant Workers
Translating Obesity and Diabetes Prevention Into the Worksite for Immigrant Populations
Status: Enrolling
Updated: 12/31/1969
Reiter Brothers Inc.
mi
from
Oxnard, CA
Click here to add this to my saved trials
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
mi
from
Charleston, SC
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Weight Loss as Therapy for Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
MUSC Gazes Research Institue
mi
from
Charleston, SC
Click here to add this to my saved trials
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated: 12/31/1969
Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center/Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Ribeirão Preto,
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity: a Proof-of-concept Study
Status: Enrolling
Updated: 12/31/1969
Clinical Hospital of Ribeirão Preto
mi
from
Ribeirão Preto,
Click here to add this to my saved trials